The market expects Regeneron (REGN) to deliver a year-over-year decline in earnings on lower revenues when it reports results ...

In the last week, the United States market has been flat, but over the past 12 months, it has risen by 18%, with earnings expected to grow by 15% per annum in the coming years. In this context of ...